We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5347:TPEXVanguard International Semiconductor Corp Analysis

Data as of 2026-09-04 - not real-time

MYR 13.62

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Tenaga Nasional Berhad is neutral at MYR 13.62, with no clear ordering between short and long averages. Over a rolling month the price has lost 5.2%. Relative strength is 24.1 — oversold — and the MACD signal is bearish. Recent trading has carved out support near MYR 13.58 and resistance around MYR 14.60.
Valuation screens as undervalued: a P/E of 17.5 sits in line with the sector average of 19.4. Sell-side targets cluster 20.8% above the current quote. Revenue is growing at 15.4% on a 6.7% profit margin. The 4.09% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 13.1%, a beta of 0.21 and a maximum drawdown of 8.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Tenaga Nasional Berhad’s fair value estimate has been revised from MYR15.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 24.1 signals oversold conditions
  • Trading below the 200-day average of 14.09
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 24.1 signals oversold conditions
  • P/E of 17.5 versus sector average of 19.4
  • Dividend yield of 4.09% looks stretched against payout coverage

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 17.5 versus sector average of 19.4
  • Dividend yield of 4.09% looks stretched against payout coverage
  • Analyst targets imply +20.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
Profit Margin6.69%
P/E Ratio17.5
ROE7.81%
ROA2.45%
Debt/Equity172.59
P/B Ratio1.6
Op. Cash FlowMYR16.1B
Free Cash FlowMYR-734787520
Industry P/E19.4

Technical Analysis

TrendNeutral
RSI24.1
SupportMYR 13.58
ResistanceMYR 14.60
MA 20MYR 14.23
MA 50MYR 14.33
MA 200MYR 14.09
MACDBearish
VolumeIncreasing
Fear & Greed Index96.14

Valuation

Fair ValueMYR 32.79
Target PriceMYR 16.45
Upside/Downside20.77%
GradeUndervalued
TypeBlend
Dividend Yield4.09%

Risk Assessment

Beta0.21
Volatility13.11%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.